Seeking Candidate Mutations That Affect Iron Homeostasis

Åsberg, 2002, Persons with screening-detected haemochromatosis: as healthy as the general population?, Scand. J. Gastroenterol., 37, 719, 10.1080/00365520212510 Beutler, 2002, Penetrance of the 845G6A (C282Y) HFE hereditary haemochromatosis mutation in the USA, Lancet, 359, 211, 10.1016/S0140-6736(02)07447-0 Beutler, 2000, Molecular characterization of a case of atransferrinemia, Blood, 96, 4071, 10.1182/blood.V96.13.4071 Lee, 2001, A study of genes that may modulate the expression of hereditary hemochromatosis: Transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin, Blood Cells Mol. Dis., 27, 783, 10.1006/bcmd.2001.0445 de Sousa, 1994, Iron overload in beta 2-microglobulin-deficient mice, Immunol. Lett., 39, 105, 10.1016/0165-2478(94)90094-9 Feder, 1997, The hemochromatosis founder mutation in HLA-H disrupts {beta}2-microglobulin interaction and cell surface expression, J. Biol. Chem., 272, 14025, 10.1074/jbc.272.22.14025 Beutler, 1997, HLA-H and associated proteins in patients with hemochromatosis, Mol. Med., 3, 397, 10.1007/BF03401686 Park, 2001, Hepcidin, a urinary antimicrobial peptide synthesized in the liver, J. Biol. Chem., 276, 7806, 10.1074/jbc.M008922200 Nicolas, 2001, Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice, Proc. Natl. Acad. Sci. USA, 98, 8780, 10.1073/pnas.151179498 Nicolas, 2002, Severe iron deficiency anemia in transgenic mice expressing liver hepcidin, Proc. Natl. Acad. Sci. USA, 99, 4596, 10.1073/pnas.072632499 Lee, 1999, The effect of transferrin polymorphisms on iron metabolism, Blood Cells Mol. Dis., 25, 374, 10.1006/bcmd.1999.0267 Fairbanks, 1971 Lee, 2001, Human transferrin G277S mutation: A risk factor for iron deficiency anaemia, Br. J. Haematol., 115, 329, 10.1046/j.1365-2141.2001.03096.x Lee, 2001, Polymorphisms in the transferrin 5′ flanking region associated with differences in total iron binding capacity: Possible implications in iron homeostasis, Blood Cells Mol. Dis., 27, 539, 10.1006/bcmd.2001.0418 Tsuchihashi, 1998, Transferrin receptor mutation analysis in hereditary hemochromatosis patients, Blood Cells Mol. Dis., 24, 317, 10.1006/bcmd.1998.0199 Lee, 2001, Mutation analysis of the transferrin receptor-2 gene in patients with iron overload, Blood Cells Mol. Dis., 27, 285, 10.1006/bcmd.2001.0381 Camaschella, 2000, The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22, Nature Genet., 25, 14, 10.1038/75534 Girelli, 2002, Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene, Gastroenterology, 122, 1295, 10.1053/gast.2002.32984 Roetto, 2001, New mutations inactivating transferrin receptor 2 in hemochromatosis type 3, Blood, 97, 2555, 10.1182/blood.V97.9.2555 Lee, 2000, Mutations in candidate genes that may influence the hemochromatosis phenotype: Ferroportin and ceruloplasmin, Blood, 96, 223a Njajou, 2001, A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis, Nature Genet., 28, 213, 10.1038/90038 Fleming, 2001, Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding, J. Clin. Invest., 108, 521, 10.1172/JCI13739 Montosi, 2001, Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene, J. Clin. Invest., 108, 619, 10.1172/JCI200113468 Njajou, 2002, The hemochromatosis N144H mutation of SLC11A3 gene in patients with type 2 diabetes, Mol. Genet. Metab., 75, 290, 10.1006/mgme.2002.3299 Roetto, 2002, A valine deletion of ferroportin 1: A common mutation in hemochromatosis type 4?, Blood, 100, 733, 10.1182/blood-2002-03-0693 Devalia, 2002, Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3), Blood, 100, 695, 10.1182/blood-2001-11-0132 Wallace, 2002, Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis, Blood, 100, 692, 10.1182/blood.V100.2.692 Lioumi, 1999, Isolation and characterization of human and mouse ZIRTL, a member of the IRT1 family of transporters, mapping within the epidermal differentiation complex, Genomics, 62, 272, 10.1006/geno.1999.5993 Eng, 1998, Sequence analyses and phylogenetic characterization of the ZIP family of metal ion transport proteins, J Membr. Biol, 166, 1, 10.1007/s002329900442 Lioumi, 1998, High-resolution YAC fragmentation map of 1q21, Genomics, 49, 200, 10.1006/geno.1998.5234 Papanikolaou, 2001, Linkage to chromosome 1q in Greek families with juvenile hemochromatosis, Blood Cells Mol. Dis., 27, 744, 10.1006/bcmd.2001.0444 Vidal, 1993, Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg, Cell, 73, 469, 10.1016/0092-8674(93)90135-D Gunshin, 1997, Cloning and characterization of a mammalian proton-coupled metal-ion transporter, Nature, 388, 482, 10.1038/41343 Fleming, 1997, Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene, Nature Genet., 16, 383, 10.1038/ng0897-383 Barton, 1999, Nramp1: A link between intracellular iron transport and innate resistance to intracellular pathogens, J. Leuk. Biol., 66, 757, 10.1002/jlb.66.5.757 Biggs, 2001, Nramp1 modulates iron homoeostasis in vivo and in vitro: Evidence for a role in cellular iron release involving de-acidification of intracellular vesicles, Eur. J. Immunol., 31, 2060, 10.1002/1521-4141(200107)31:7<2060::AID-IMMU2060>3.0.CO;2-L LeBoeuf, 1995, Dissociation between tissue iron concentrations and transferrin saturation among inbred mouse strains, J. Lab. Clin. Med., 126, 128 Lee, 1998, The human nramp2 gene: Characterization of the gene structure, alternative splicing, promoter region and polymorphisms, Blood Cells Mol. Dis., 24, 199, 10.1006/bcmd.1998.0186 Fleming, 1998, Nramp2 is mutated in the anemic belgrade (b) rat: evidence of a role for nramp2 in endosomal iron transport, Proc. Natl. Acad. Sci. USA, 95, 1148, 10.1073/pnas.95.3.1148 Conrad, 1999, Iron absorption and transport, Am. J. Med. Sci., 318, 213, 10.1016/S0002-9629(15)40626-3 Solheim, 1997, Prominence of b2-microglobulin, class 1 heavy chain conformation, and tapasin in the interactions of class 1 heavy chain with calreticulin and the transporter associated with antigen processing, J. Immunol., 158, 2236, 10.4049/jimmunol.158.5.2236 Cazzola, 2002, A novel deletion of the l-ferritin iron-responsive element responsible for severe hereditary hyperferritinaemia-cataract syndrome, Br. J. Haematol., 116, 667, 10.1046/j.0007-1048.2001.03310.x Brooks, 2002, Ferritin crystal cataracts in hereditary hyperferritinemia cataract syndrome, Invest. Ophthalmol. Vis. Sci., 43, 1121 Aguilar-Martinez, 1996, A novel mutation in the iron responsive element of ferritin L-subunit gene as a cause for hereditary hyperferritinemia-cataract syndrome, Blood, 88, 1895, 10.1182/blood.V88.5.1895.bloodjournal8851895 Cicilano, 1999, Recurrent mutations in the iron regulatory element of L-ferritin in hereditary hyperferritinemia-cataract syndrome, Haematologica, 84, 489 Curtis, 2001, Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease, Nature Genet., 28, 350, 10.1038/ng571 Ferreira, 2001, H ferritin knockout mice: A model of hyperferritinemia in the absence of iron overload, Blood, 98, 525, 10.1182/blood.V98.3.525 Kato, 2001, A mutation in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload, Am. J. Hum. Genet., 69, 191, 10.1086/321261 LaVaute, 2001, Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice, Nature Genet., 27, 209, 10.1038/84859 Lee, 2002, Mutations in iron-regulatory protein 2 (IRP2) and lack of association with sporadic Parkinson's disease, Mov. Disord., 17, 1302, 10.1002/mds.10253 Langlois, 2000, The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males, Clin. Chem., 46, 1619, 10.1093/clinchem/46.10.1619 Delanghe, 2002, Haptoglobin polymorphism and body iron stores, Clin. Chem. Lab. Med., 40, 212, 10.1515/CCLM.2002.035 Van Vlierberghe, 2001, Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients, J. Hepatol., 35, 707, 10.1016/S0168-8278(01)00203-3 Beutler, 2002, Haptoglobin polymorphism and iron homeostasis, Clin. Chem., 10.1093/clinchem/48.12.2232 Kawashima, 2002, Heme oxygenase-1 deficiency: The first autopsy case, Hum. Pathol., 33, 125, 10.1053/hupa.2002.30217 Yachie, 1999, Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency, J. Clin. Invest., 103, 129, 10.1172/JCI4165 Ferris, 1999, Haem oxygenase-1 prevents cell death by regulating cellular iron, Nat. Cell Biol, 1, 152, 10.1038/11072 Miller, 1991, Iron-independent induction of ferritin H chain by tumor necrosis factor, Proc. Natl. Acad. Sci. USA, 88, 4946, 10.1073/pnas.88.11.4946 Warren, 1993, The role of iron in the cytotoxicity of tumor necrosis factor, Lymph. Cytokine Res., 12, 75 Kwak, 1995, Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha, J. Biol. Chem., 270, 15285, 10.1074/jbc.270.25.15285 Tsuji, 1991, Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain, J Biol Chem, 266, 7257, 10.1016/S0021-9258(20)89638-0 Alvarez-Hernandez, 1989, Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor, Lab. Invest., 61, 319 Scaccabarozzi, 2000, Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells, Br. J. Haematol., 110, 978, 10.1046/j.1365-2141.2000.02280.x Gordeuk, 1992, Decreased concentrations of tumor necrosis factor-a in supernatants of monocytes from homozygotes for hereditary hemochromatosis, Blood, 79, 1855, 10.1182/blood.V79.7.1855.1855 Fargion, 2001, Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis, Blood, 97, 3707, 10.1182/blood.V97.12.3707 Beutler, 2002, Tumor necrosis factor a promoter polymorphisms and liver abnormalities of homozygotes for the c.845 G6A (C282Y) hereditary hemochromatosis mutation, Blood, 100, 2268, 10.1182/blood-2002-05-1520 Baribault, 1993, Mid-gestational lethality in mice lacking keratin 8, Genes Dev., 7, 1191, 10.1101/gad.7.7a.1191 Ku, 2001, Keratin 8 mutations in patients with cryptogenic liver disease, N. Engl. J. Med., 344, 1580, 10.1056/NEJM200105243442103 Ku, 1997, Mutation of human keratin 18 in association with cryptogenic cirrhosis, J. Clin. Invest., 99, 19, 10.1172/JCI119127 Sheldon, 1935 Whitelaw, 2001, Retrotransposons as epigenetic mediators of phenotypic variation in mammals, Nature Genet., 27, 361, 10.1038/86850 Rosendaal, 1999, Venous thrombosis: a multicausal disease, Lancet, 353, 1167, 10.1016/S0140-6736(98)10266-0 Beutler, 1981, The effect of alpha-thalassemia on the expression of the beta-thalassemia/HPFH heterozygote in a black family, Blood, 57, 1132, 10.1182/blood.V57.6.1132.1132 Kaplan, 1997, Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: A dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia, Proc. Natl. Acad. Sci. USA, 94, 12128, 10.1073/pnas.94.22.12128 Roetto, 1999, Juvenile hemochromatosis locus maps to chromosome 1q, Am. J. Hum. Genet., 64, 1388, 10.1086/302379